Our approval as a Zigbee certification test lab reinforces our commitment to helping companies bring secure, reliable, and compliant devices to market faster.” — Mariusz Malkowski, Chief Technology ...
TRIDENT-1 study is enrolling patients with ROS1+ advanced NSCLC and NTRK+ advanced solid tumors. The registrational Phase 2 portion of TRIDENT-1 study is a multi-center trial evaluating repotrectinib ...
NEW YORK--(BUSINESS WIRE)-- ATL Partners (“ATL”), a sector-focused private equity firm, today announced it has completed the sale of Geost, LLC (“Geost”), a subsidiary of its portfolio company ...
Becoming an authorized Matter 1.4 test lab, alongside our existing expertise in Z-Wave and Zigbee, underscores our dedication to supporting the broader industry with world-class testing services.” — ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results